Nc Chakravarthy

Akesiss, “on a health mission with a global vision” is a rising Star in the Pharmaceutical Industry, started the full-fledged operations with the support of U.S based NRI group. Akesiss, today is marching ahead aggressively covering 15 therapeutic segments with its vast domestic reach across India and it has the right molecular selection which is widely accepted by medical fraternity which also ensures a rapid and sustained growth of the company. Akesiss ensures innovations in various drug delivery systems as it implements the stringent protocols to ensure maximum drug efficacy, compliance and less side effects hence optimally benefiting patients. Business: Currently, Akesiss currently operates through six marketing divisions – Zalvo, Glyvo, Lazo, Carvo, MSD & CCD. Zalvo is the Multi- Speciality Division of Akesiss catering to Gynecology, Urology and General Medicine. Glyvo is the Diabetes care division catering to Specialties like Endocrinology, Diabetology & General medicine with an additional focus on infertility specialists. Lazo caters to Orthopedics, Nephrology and General Medicine. Carvo is the exclusive Cardiology division of Akesiss, MSD is a multispecialty division focusing on Gynecology, General medicine & Orthopedics, whereas, CCD is the division which caters to all surgical specialties. Akesiss has created an Intellectual property for more than 80 brand names permitted to be used as the registered brands. Global Accreditation: Akesiss is an ISO 9001:2008 certified company by prestigious Certification body, “Bureau Verities of France” in accreditation with “UKAS“ of United Kingdom. Quality Excellence: The Commitment for Excellence in Quality would be the driving force for the success of Akesiss as it maintains highest quality at par with International standards. All formulations are manufactured in Ultra-modern, R&D based, WHO - GMP Certified production plants. Moreover Akesiss offers this quality at an affordable cost to the patients.